Latest Frontiers and Applications in Target and Drug Discovery Field

Dear Colleagues,

In recent decades, we have witnessed a worrying increase in disease outbreaks, and despite the enormous progress made by the scientific community, it is paramount to individualize pioneering drug and target discovery approaches for the biomedical field to improve patient life expectancy.

The proposed new methods, such as using large-scale omics data, the circular bioeconomy, precision medicine, and bioinformatics approaches, enable us to understand the molecular mechanisms of the onset of disorders and rare diseases, providing leading compounds to tackle such pathologies.

This research topic aims to shed light on the pivotal molecular mechanisms involved in disorders through innovative in vitro and in silico strategies.

As a Guest Editor of this Special Issue, I cordially invite scholars and experts to submit original research, reviews, and perspectives on the in vitro advancements and computational methods in this field.

Areas of interest include, but are not limited to, the following:

• In vitro and bioinformatics methods for the prediction and validation of novel selective leading compounds and drug targets;
• In vitro and bioinformatics approaches to rare diseases;
• Target and drug discovery strategies within the circular bioeconomy

Dr. Alfonso Trezza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• molecular dynamics and docking simulation
• molecular modeling
• target and drug discovery
• precision medicine
• circular bioeconomy